Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial
暂无分享,去创建一个
[1] J. Kurtzke. A New Scale for Evaluating Disability in Multiple Sclerosis , 1955, Neurology.
[2] Jacob Cohen. A Coefficient of Agreement for Nominal Scales , 1960 .
[4] H. Weiner,et al. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. , 1983, The New England journal of medicine.
[5] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[6] M. Lavenhar,et al. EFFECT OF TOTAL LYMPHOID IRRADIATION IN CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS , 1986, The Lancet.
[7] M. Wenala. Cyclophosphamide in chronic progressive multiple sclerosis. , 1987, NITA.
[8] D. Paty,et al. Scales for rating impairment in multiple sclerosis , 1988, Neurology.
[9] L. Fratiglioni,et al. Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis. , 1988, Archives of neurology.
[10] Inter-rater variability on multiple sclerosis disability scales in a blinded, prospective clinical trial , 1989 .
[11] J. Noseworthy,et al. A referendum on clinical trial research in multiple sclerosis , 1989, Neurology.
[12] M. R. Mickey,et al. A placebo‐controlled, randomized, double‐masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis , 1989, Neurology.